📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2 (2022)

First Author: Pattni K

Attributed to: Impact of network-structured populations on evolution funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12879-022-07239-z

PubMed Identifier: 35307024

Publication URI: http://europepmc.org/abstract/MED/35307024

Type: Journal Article/Review

Parent Publication: BMC Infectious Diseases

Issue: 1

ISSN: 1471-2334